Home / Inspections / 1108391

FDA Inspection 1108391 — Carter BloodCare - Arlington

Carter BloodCare - Arlington — FEI 1677509

The FDA completed an inspection of Carter BloodCare - Arlington on October 17, 2019 in Arlington, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 17, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Arlington, TX (United States)

Facility

Other inspections at this facility

  • 1271731 (NAI Thu May 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1058076 (NAI Thu May 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 989472 (NAI Thu Sep 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 875657 (NAI Wed Apr 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 791165 (NAI Wed Jul 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources